avatar for C. Ola Landgren

C. Ola Landgren

Memorial Sloan Kettering Cancer Center
Professor of Medicine and Chief of Myeloma Service
Dr Ola Landgren has designed studies to define biological mechanisms of transformation from myeloma precursor disease to myeloma. He has developed (1) early interventional clinical trials for patients with high-risk smoldering myeloma to delay/prevent transformation; (2) modern intervention trials for newly diagnosed multiple myeloma patients; and (3) cell- and molecular -based strategies to define minimal residual disease (MRD) detection post-therapy with the aim to improve clinical outcomes.

My Speakers Sessions

Wednesday, June 21

10:30am CDT